NASDAQ
China Pharma Holdings, Inc. (CPHI) has a revenue compound annual growth rate of -17.53% over 5 years and -14.71% over 10 years. Revenue CAGR shows the compound annual growth rate of a company's total sales, indicating the pace of top-line expansion.
No price data available for this timeframe.